首页
情报
资讯
快讯
话题
情绪
报告
机会
融资
Launch Pool
代币解锁
日历
预测市场
数据
市场
行情
证券
巨鲸
评级
板块
链
交易所
钱包
发现
失乐园
活动
AI
扫码下载 WOOFUN App
支持 iOS / Android
绑定钱包
登录/注册
消息提醒
×
登录后查看消息
查看全部消息
管理订阅
mcuban：Great job Wendell - Woofun 情绪
首页
情报
情绪
Great job Wendell
mcuban
@mcuban
X
2026-10-16 20:40
·
209.4K 阅读
·
twitter
Great job Wendell
翻译
400
41
22
0
209.4K
阅读
0
01
AI 解读
02
立场与情绪分析
03
市场影响归因
ETH
BTC
SP500
ETH / BTC / SP500 价格走势
ETH
BTC
+0.92%
-0.38%
-1.67%
−3h
推文 20:40
+3h
EVENT · 推文发布
推文前 1H
$2,478.97
19:40
推文发布
$2,474.34
20:40
推文后 30MIN
-0.32%
推文后 1H
-0.51%
推文后 24H
-1.83%
04
类似观点 KOL
中立
评论与回复
最新
最热
我
回复
@用户
0/800
发布
暂无评论
推特动态
@mcuban
The cost savings
@costplusdrugs
could have offered for Urogynecologic medications https://t.co/oFW6dvLnob
2026-10-21 02:27
41
7
Right or Wrong ? Switching costs for consumer AI, won't approach zero until there is a standardized export format for what is in a model's memory. The more a consumer uses a model, the more it's memory stores. The more work to export and import I'm not saying it can't be done. Obviously you can import from one model to another. But for regular users, that's a lot more difficult than saving to an xls or doc file Curious what people think ?
2026-10-19 06:20
400
20
Using Robots and AI, and smart people, Cost Plus Drugs have shrunk the ability to manufacture a line of drugs to the size of a tractor trailer. It can be shipped anywhere. It can be daisy chained to scale. Each Pod can be used for a different type of medication. Including N of 1 therapies.
2026-10-19 04:15
628
58
It’s really simple. Our Robots and AI vs their Robots and AI. If we can catch up on robotics/software , and can stay ahead on AI, there is zero reason manufacturing won’t come back, or initiate here. At Cost Plus Drugs, the only thing holding us back from making generic drugs cheaper in Dallas than we can buy from Asia, are the fees we have to pay.
2026-10-18 22:28
1.8K
107
This can't be legal , can it ? Any healthcare lawyers do people bono work ?
2026-10-17 05:26
1.1K
97
在 X 查看全部
相关行情
GREAT
1
$17.24
-0.01%
JOB
1
$0.0₅901
--
评论与回复
暂无评论